These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20271028)

  • 1. Use of pyribenzamine in prevention of histamine-induced gastric acidity and headache and in treatment of hypersensitiveness to cold.
    PERRY EL; HORTON BT
    Am J Med Sci; 1947 Nov; 214(5):553-8. PubMed ID: 20271028
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of the "antihistaminic" effect of pyribenzamine administered by various routes.
    LeVAN P; STERNBERG TH; PERRY DJ
    Calif Med; 1951 Apr; 74(4):256-9. PubMed ID: 14821823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of tripelennamine hydrochloride (pyribenzamine) on the release of histamine during in vitro hemolytic reaction in rabbit blood.
    CARRYER HM; CODE CF
    J Allergy; 1950 Jul; 21(4):314-7. PubMed ID: 15428185
    [No Abstract]   [Full Text] [Related]  

  • 4. Histamine antagonists; pyridil-N'benzyl-N-dimethyl-ethylenediamine (pyribenzamine) in symptomatic treatment of allergic manifestations.
    FEINBERG SM; FRIEDLAENDER S
    Am J Med Sci; 1947 Jan; 213(1):58-60. PubMed ID: 20279845
    [No Abstract]   [Full Text] [Related]  

  • 5. Pyribenzamine (n'-pyridyl-n'-benzyl-n-dimethylethylenediamine HC1), an antagonist of histamine.
    MAYER RL; HAYS HW
    J Lab Clin Med; 1946 Jul; 31(7):749-51. PubMed ID: 20992876
    [No Abstract]   [Full Text] [Related]  

  • 6. Pyribenzamine fever; report of a case.
    FANBURG SJ
    J Med Soc N J; 1948 Aug; 45(8):392. PubMed ID: 18875832
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical use of a new antihistaminic compound (pyribenzamine) in certain cutaneous disorders.
    OSBORNE ED; JORDON JW; RAUSCH NG
    Arch Derm Syphilol; 1947 Mar; 55(3):309-21. PubMed ID: 20287961
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of essential dysmenorrhea with an antihistaminic drug (pyribenzamine R HC1).
    HOFFMAN DB
    J Med Soc N J; 1950 Jun; 47(6):287-8. PubMed ID: 15422308
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of the antihistamine compound pyribenzamine on colonic activity in unanesthetized dogs.
    HOEKSTRA J; STEGGERDA FR
    Fed Proc; 1946; 5(1 Pt 2):48. PubMed ID: 21066034
    [No Abstract]   [Full Text] [Related]  

  • 10. The activity of pyribenzamine and related compounds with special reference to their mode of action.
    MAYER RL
    Ann N Y Acad Sci; 1950 Apr; 50(9):1127-41. PubMed ID: 15413928
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacodynamic studies of a new antihistaminic agent, pyribenzamine (N,N-dimethyl-N'-benzyl-N'-(alpha-pyridyl)-ethylene diamine hydrochloride).
    YONKMAN FF; OPPENHEIMER E
    J Pharmacol Exp Ther; 1947 Jan; 89(1):31-41. PubMed ID: 20281337
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolonged protection of guinea pigs against histamine by means of pellets of pyribenzamine in beeswax implanted subcutaneously.
    KELLNER A; CORRELL JW
    J Immunol; 1948 Nov; 60(3):339-43. PubMed ID: 18890192
    [No Abstract]   [Full Text] [Related]  

  • 13. Whooping cough; pyribenzamine in its symptomatic treatment.
    HELMAN J
    S Afr Med J; 1949 Nov; 23(48):962. PubMed ID: 15407991
    [No Abstract]   [Full Text] [Related]  

  • 14. An unusual reaction following the use of pyribenzamine.
    TOWERS PA; GIUFFRA LJ
    N Y State J Med; 1950 Jan; 50(2):214. PubMed ID: 15399048
    [No Abstract]   [Full Text] [Related]  

  • 15. The treatment of itching dermatoses with antihistaminic drugs with particular reference to pyribenzamine.
    BAER RL; SULZBERGER MB; WITTEN VH
    Am Pract Dig Treat; 1947 Dec; 2(4):237-40. PubMed ID: 18898029
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of histamine whealing in human skin by pyribenzamine hydrochloride using iontophoretic technique.
    AARON TH; ABRAMSON HA
    Proc Soc Exp Biol Med; 1947 Jun; 65(2):272. PubMed ID: 20250458
    [No Abstract]   [Full Text] [Related]  

  • 17. The pharmacology, physiology, and clinical evaluation of the new antihistaminic drugs (pyribenzamine and benadryl).
    ARBESMAN CE
    N Y State J Med; 1947 Aug; 47(16):1775-81. PubMed ID: 20255858
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute urticaria following pyribenzamine therapy; a case report.
    LONDON ID; MOODY M
    J Invest Dermatol; 1949 Oct; 13(4):217-9. PubMed ID: 15400079
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacodynamic studies of a new antihistamine agent, N'-pyridyl-N benzyl-N-dimethylethylene diamine HCI, pyribenzamine HCI; effects on salivation, nictitating membrane, lachrymation, pupil and blood pressure.
    YONKMAN FF; CHESS D
    J Pharmacol Exp Ther; 1946 Jul; 87():256-64. PubMed ID: 20994726
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological properties of antihistamine drugs, benadryl, pyribenzamine and neoantergan.
    SHERROD TR; LOEW ER; SCHLOEMER HF
    J Pharmacol Exp Ther; 1947 Mar; 89(3):247-55. PubMed ID: 20290428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.